4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0000950170-25-038717
Options or other derivatives
- Chief Medical Officer acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Kabbinavar Fairooz Chief Medical Officer | 2025-03-11 | Grant or award · Stock Options | +150,000 | 780,008 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…